APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lipid Nanoparticle (LNP) Services

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lipid Nanoparticle (LNP) Services Industry Growth and Trends Forecast to 2032

Report ID 174177340115 January 2026124 pages

Choose your research edition.

Industry ResearchLipid Nanoparticle (LNP) Services Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid Nanoparticle (LNP) Services Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Lipid Nanoparticle (LNP) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid Nanoparticle (LNP) Services Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Lipid Nanoparticle (LNP) Services Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

According to APO Research, the global Lipid Nanoparticle (LNP) Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lipid Nanoparticle (LNP) Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lipid Nanoparticle (LNP) Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lipid Nanoparticle (LNP) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Lipid Nanoparticle (LNP) Services market include PreciGenome, Creative Biolabs, Genscript, ReciBioPharm, CD Bioparticles, Vernal Biosciences, Hzymes Biotech, LipExoGen and Evonik, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lipid Nanoparticle (LNP) Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lipid Nanoparticle (LNP) Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lipid Nanoparticle (LNP) Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lipid Nanoparticle (LNP) Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Lipid Nanoparticle (LNP) Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lipid Nanoparticle (LNP) Services Market by Company

PreciGenome

Creative Biolabs

Genscript

ReciBioPharm

CD Bioparticles

Vernal Biosciences

Hzymes Biotech

LipExoGen

Evonik

Merck

Cayman

Echelon

WuXi STA

BOC Sciences

Carcell

Cambridge Bioscience

FluidicLab

Guangzhou Anernor Biotechnology

Nanjing Yasmin Biotechnology

vectorbuilder

Helix Biotech

FUJIFILM Holdings

Ascendia Pharmaceuticals

Catalent

Polymun Scientific

Wacker

Corden Pharma

Cytiva

Croda International

Nippon Fine Chemical

Patheon

Lonza

Lipid Nanoparticle (LNP) Services Segment by Type

Formulation Service

Development Service

Others

Lipid Nanoparticle (LNP) Services Segment by Application

Drug Delivery

Diagnostics

Gene Therapy

Others

Lipid Nanoparticle (LNP) Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticle (LNP) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticle (LNP) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticle (LNP) Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Lipid Nanoparticle (LNP) Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Lipid Nanoparticle (LNP) Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Lipid Nanoparticle (LNP) Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Lipid Nanoparticle (LNP) Services Market Share by Region (2021-2026) Table 4. Global Lipid Nanoparticle (LNP) Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Lipid Nanoparticle (LNP) Services Market Share by Region (2027-2032) Table 6. Global Lipid Nanoparticle (LNP) Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Lipid Nanoparticle (LNP) Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Lipid Nanoparticle (LNP) Services Market Size Share by Type (2021-2026) Table 9. Global Lipid Nanoparticle (LNP) Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Lipid Nanoparticle (LNP) Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Lipid Nanoparticle (LNP) Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Lipid Nanoparticle (LNP) Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Lipid Nanoparticle (LNP) Services Market Size Share by Application (2021-2026) Table 24. Global Lipid Nanoparticle (LNP) Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Lipid Nanoparticle (LNP) Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Lipid Nanoparticle (LNP) Services Industry Trends Table 37. Lipid Nanoparticle (LNP) Services Industry Drivers Table 38. Lipid Nanoparticle (LNP) Services Industry Opportunities and Challenges Table 39. Lipid Nanoparticle (LNP) Services Industry Restraints Table 40. Global Lipid Nanoparticle (LNP) Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Company (2021-2026) Table 42. Global Lipid Nanoparticle (LNP) Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Lipid Nanoparticle (LNP) Services Key Company Headquarters & Area Served Table 44. Global Lipid Nanoparticle (LNP) Services Company, Product Type & Application Table 45. Global Lipid Nanoparticle (LNP) Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Lipid Nanoparticle (LNP) Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. PreciGenome Company Information Table 49. PreciGenome Business Overview Table 50. PreciGenome Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. PreciGenome Lipid Nanoparticle (LNP) Services Product Portfolio Table 52. PreciGenome Recent Development Table 53. Creative Biolabs Company Information Table 54. Creative Biolabs Business Overview Table 55. Creative Biolabs Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Creative Biolabs Lipid Nanoparticle (LNP) Services Product Portfolio Table 57. Creative Biolabs Recent Development Table 58. Genscript Company Information Table 59. Genscript Business Overview Table 60. Genscript Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Genscript Lipid Nanoparticle (LNP) Services Product Portfolio Table 62. Genscript Recent Development Table 63. ReciBioPharm Company Information Table 64. ReciBioPharm Business Overview Table 65. ReciBioPharm Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. ReciBioPharm Lipid Nanoparticle (LNP) Services Product Portfolio Table 67. ReciBioPharm Recent Development Table 68. CD Bioparticles Company Information Table 69. CD Bioparticles Business Overview Table 70. CD Bioparticles Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. CD Bioparticles Lipid Nanoparticle (LNP) Services Product Portfolio Table 72. CD Bioparticles Recent Development Table 73. Vernal Biosciences Company Information Table 74. Vernal Biosciences Business Overview Table 75. Vernal Biosciences Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Vernal Biosciences Lipid Nanoparticle (LNP) Services Product Portfolio Table 77. Vernal Biosciences Recent Development Table 78. Hzymes Biotech Company Information Table 79. Hzymes Biotech Business Overview Table 80. Hzymes Biotech Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Hzymes Biotech Lipid Nanoparticle (LNP) Services Product Portfolio Table 82. Hzymes Biotech Recent Development Table 83. LipExoGen Company Information Table 84. LipExoGen Business Overview Table 85. LipExoGen Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. LipExoGen Lipid Nanoparticle (LNP) Services Product Portfolio Table 87. LipExoGen Recent Development Table 88. Evonik Company Information Table 89. Evonik Business Overview Table 90. Evonik Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Evonik Lipid Nanoparticle (LNP) Services Product Portfolio Table 92. Evonik Recent Development Table 93. Merck Company Information Table 94. Merck Business Overview Table 95. Merck Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Merck Lipid Nanoparticle (LNP) Services Product Portfolio Table 97. Merck Recent Development Table 98. Cayman Company Information Table 99. Cayman Business Overview Table 100. Cayman Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Cayman Lipid Nanoparticle (LNP) Services Product Portfolio Table 102. Cayman Recent Development Table 103. Echelon Company Information Table 104. Echelon Business Overview Table 105. Echelon Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Echelon Lipid Nanoparticle (LNP) Services Product Portfolio Table 107. Echelon Recent Development Table 108. WuXi STA Company Information Table 109. WuXi STA Business Overview Table 110. WuXi STA Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. WuXi STA Lipid Nanoparticle (LNP) Services Product Portfolio Table 112. WuXi STA Recent Development Table 113. BOC Sciences Company Information Table 114. BOC Sciences Business Overview Table 115. BOC Sciences Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. BOC Sciences Lipid Nanoparticle (LNP) Services Product Portfolio Table 117. BOC Sciences Recent Development Table 118. Carcell Company Information Table 119. Carcell Business Overview Table 120. Carcell Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Carcell Lipid Nanoparticle (LNP) Services Product Portfolio Table 122. Carcell Recent Development Table 123. Cambridge Bioscience Company Information Table 124. Cambridge Bioscience Business Overview Table 125. Cambridge Bioscience Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Cambridge Bioscience Lipid Nanoparticle (LNP) Services Product Portfolio Table 127. Cambridge Bioscience Recent Development Table 128. FluidicLab Company Information Table 129. FluidicLab Business Overview Table 130. FluidicLab Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. FluidicLab Lipid Nanoparticle (LNP) Services Product Portfolio Table 132. FluidicLab Recent Development Table 133. Guangzhou Anernor Biotechnology Company Information Table 134. Guangzhou Anernor Biotechnology Business Overview Table 135. Guangzhou Anernor Biotechnology Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Guangzhou Anernor Biotechnology Lipid Nanoparticle (LNP) Services Product Portfolio Table 137. Guangzhou Anernor Biotechnology Recent Development Table 138. Nanjing Yasmin Biotechnology Company Information Table 139. Nanjing Yasmin Biotechnology Business Overview Table 140. Nanjing Yasmin Biotechnology Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Nanjing Yasmin Biotechnology Lipid Nanoparticle (LNP) Services Product Portfolio Table 142. Nanjing Yasmin Biotechnology Recent Development Table 143. vectorbuilder Company Information Table 144. vectorbuilder Business Overview Table 145. vectorbuilder Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. vectorbuilder Lipid Nanoparticle (LNP) Services Product Portfolio Table 147. vectorbuilder Recent Development Table 148. Helix Biotech Company Information Table 149. Helix Biotech Business Overview Table 150. Helix Biotech Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Helix Biotech Lipid Nanoparticle (LNP) Services Product Portfolio Table 152. Helix Biotech Recent Development Table 153. FUJIFILM Holdings Company Information Table 154. FUJIFILM Holdings Business Overview Table 155. FUJIFILM Holdings Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. FUJIFILM Holdings Lipid Nanoparticle (LNP) Services Product Portfolio Table 157. FUJIFILM Holdings Recent Development Table 158. Ascendia Pharmaceuticals Company Information Table 159. Ascendia Pharmaceuticals Business Overview Table 160. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Services Product Portfolio Table 162. Ascendia Pharmaceuticals Recent Development Table 163. Catalent Company Information Table 164. Catalent Business Overview Table 165. Catalent Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Catalent Lipid Nanoparticle (LNP) Services Product Portfolio Table 167. Catalent Recent Development Table 168. Polymun Scientific Company Information Table 169. Polymun Scientific Business Overview Table 170. Polymun Scientific Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Polymun Scientific Lipid Nanoparticle (LNP) Services Product Portfolio Table 172. Polymun Scientific Recent Development Table 173. Wacker Company Information Table 174. Wacker Business Overview Table 175. Wacker Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Wacker Lipid Nanoparticle (LNP) Services Product Portfolio Table 177. Wacker Recent Development Table 178. Corden Pharma Company Information Table 179. Corden Pharma Business Overview Table 180. Corden Pharma Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 181. Corden Pharma Lipid Nanoparticle (LNP) Services Product Portfolio Table 182. Corden Pharma Recent Development Table 183. Cytiva Company Information Table 184. Cytiva Business Overview Table 185. Cytiva Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 186. Cytiva Lipid Nanoparticle (LNP) Services Product Portfolio Table 187. Cytiva Recent Development Table 188. Croda International Company Information Table 189. Croda International Business Overview Table 190. Croda International Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 191. Croda International Lipid Nanoparticle (LNP) Services Product Portfolio Table 192. Croda International Recent Development Table 193. Nippon Fine Chemical Company Information Table 194. Nippon Fine Chemical Business Overview Table 195. Nippon Fine Chemical Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 196. Nippon Fine Chemical Lipid Nanoparticle (LNP) Services Product Portfolio Table 197. Nippon Fine Chemical Recent Development Table 198. Patheon Company Information Table 199. Patheon Business Overview Table 200. Patheon Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 201. Patheon Lipid Nanoparticle (LNP) Services Product Portfolio Table 202. Patheon Recent Development Table 203. Lonza Company Information Table 204. Lonza Business Overview Table 205. Lonza Lipid Nanoparticle (LNP) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 206. Lonza Lipid Nanoparticle (LNP) Services Product Portfolio Table 207. Lonza Recent Development Table 208. North America Lipid Nanoparticle (LNP) Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 209. North America Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026) & (US$ Million) Table 210. North America Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2026) Table 211. North America Lipid Nanoparticle (LNP) Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 212. North America Lipid Nanoparticle (LNP) Services Market Share Forecast by Country (2027-2032) Table 213. Europe Lipid Nanoparticle (LNP) Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 214. Europe Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026) & (US$ Million) Table 215. Europe Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2026) Table 216. Europe Lipid Nanoparticle (LNP) Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 217. Europe Lipid Nanoparticle (LNP) Services Market Share Forecast by Country (2027-2032) Table 218. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 219. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026) & (US$ Million) Table 220. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2026) Table 221. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 222. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Share Forecast by Country (2027-2032) Table 223. Latin America Lipid Nanoparticle (LNP) Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 224. Latin America Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026) & (US$ Million) Table 225. Latin America Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2026) Table 226. Latin America Lipid Nanoparticle (LNP) Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 227. Latin America Lipid Nanoparticle (LNP) Services Market Share Forecast by Country (2027-2032) Table 228. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 229. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026) & (US$ Million) Table 230. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2026) Table 231. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 232. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Share Forecast by Country (2027-2032) Table 233. Research Programs/Design for This Report Table 234. Authors List of This Report Table 235. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Lipid Nanoparticle (LNP) Services Product Image Figure 3. Global Lipid Nanoparticle (LNP) Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Lipid Nanoparticle (LNP) Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Lipid Nanoparticle (LNP) Services Market Share by Region: 2025 VS 2032 Figure 6. Global Lipid Nanoparticle (LNP) Services Market Share by Region (2021-2032) Figure 7. North America Lipid Nanoparticle (LNP) Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Lipid Nanoparticle (LNP) Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Lipid Nanoparticle (LNP) Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Formulation Service Image Figure 13. Global Formulation Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Development Service Image Figure 15. Global Development Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Lipid Nanoparticle (LNP) Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Lipid Nanoparticle (LNP) Services Market Share by Type 2025 VS 2032 Figure 20. North America Lipid Nanoparticle (LNP) Services Market Size Share by Type (2021-2032) Figure 21. Europe Lipid Nanoparticle (LNP) Services Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Share by Type (2021-2032) Figure 23. Latin America Lipid Nanoparticle (LNP) Services Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Lipid Nanoparticle (LNP) Services Market Size Share by Type (2021-2032) Figure 25. Drug Delivery Image Figure 26. Global Drug Delivery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Diagnostics Image Figure 28. Global Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Gene Therapy Image Figure 30. Global Gene Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Lipid Nanoparticle (LNP) Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Lipid Nanoparticle (LNP) Services Market Share by Application 2025 VS 2032 Figure 35. North America Lipid Nanoparticle (LNP) Services Market Size Share by Application (2021-2032) Figure 36. Europe Lipid Nanoparticle (LNP) Services Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Share by Application (2021-2032) Figure 38. Latin America Lipid Nanoparticle (LNP) Services Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Lipid Nanoparticle (LNP) Services Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Lipid Nanoparticle (LNP) Services Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Lipid Nanoparticle (LNP) Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Lipid Nanoparticle (LNP) Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2032) Figure 45. Europe Lipid Nanoparticle (LNP) Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Lipid Nanoparticle (LNP) Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2032) Figure 48. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2032) Figure 51. Latin America Lipid Nanoparticle (LNP) Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Lipid Nanoparticle (LNP) Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2032) Figure 54. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Lipid Nanoparticle (LNP) Services Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Formulation Service
  • Development Service
  • Others
Applications
  • Drug Delivery
  • Diagnostics
  • Gene Therapy
  • Others
Companies covered
  • PreciGenome
  • Creative Biolabs
  • Genscript
  • ReciBioPharm
  • CD Bioparticles
  • Vernal Biosciences
  • Hzymes Biotech
  • LipExoGen
  • Evonik
  • Merck
  • Cayman
  • Echelon
  • WuXi STA
  • BOC Sciences
  • Carcell
  • Cambridge Bioscience
  • FluidicLab
  • Guangzhou Anernor Biotechnology
  • Nanjing Yasmin Biotechnology
  • vectorbuilder
  • Helix Biotech
  • FUJIFILM Holdings
  • Ascendia Pharmaceuticals
  • Catalent
  • Polymun Scientific
  • Wacker
  • Corden Pharma
  • Cytiva
  • Croda International
  • Nippon Fine Chemical
  • Patheon
  • Lonza

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Lipid Nanoparticle (LNP) Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Lipid Nanoparticle (LNP) Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Lipid Nanoparticle (LNP) Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Lipid Nanoparticle (LNP) Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Lipid Nanoparticle (LNP) Services Market Size (2021-2032)
  8. 1.5.1 North America Lipid Nanoparticle (LNP) Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Lipid Nanoparticle (LNP) Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Lipid Nanoparticle (LNP) Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size Growth Rate (2021-2032)
2 Lipid Nanoparticle (LNP) Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Formulation Service
  3. 2.1.2 Development Service
  4. 2.1.3 Others
  5. 2.2 Global Lipid Nanoparticle (LNP) Services Market Size by Type
  6. 2.2.1 Global Lipid Nanoparticle (LNP) Services Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Lipid Nanoparticle (LNP) Services Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Lipid Nanoparticle (LNP) Services Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Lipid Nanoparticle (LNP) Services Market Size by Regions
  10. 2.3.1 North America Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Lipid Nanoparticle (LNP) Services Market Size Breakdown by Type (2021-2026)
3 Lipid Nanoparticle (LNP) Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Drug Delivery
  3. 3.1.2 Diagnostics
  4. 3.1.3 Gene Therapy
  5. 3.1.4 Others
  6. 3.2 Global Lipid Nanoparticle (LNP) Services Market Size by Application
  7. 3.2.1 Global Lipid Nanoparticle (LNP) Services Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Lipid Nanoparticle (LNP) Services Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Lipid Nanoparticle (LNP) Services Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Lipid Nanoparticle (LNP) Services Market Size by Regions
  11. 3.3.1 North America Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Lipid Nanoparticle (LNP) Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Lipid Nanoparticle (LNP) Services Industry Trends
  2. 4.2 Lipid Nanoparticle (LNP) Services Industry Drivers
  3. 4.3 Lipid Nanoparticle (LNP) Services Industry Opportunities and Challenges
  4. 4.4 Lipid Nanoparticle (LNP) Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Lipid Nanoparticle (LNP) Services Revenue (2021-2026)
  2. 5.2 Global Lipid Nanoparticle (LNP) Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Lipid Nanoparticle (LNP) Services Key Company Headquarters & Area Served
  4. 5.4 Global Lipid Nanoparticle (LNP) Services Company, Product Type & Application
  5. 5.5 Global Lipid Nanoparticle (LNP) Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Lipid Nanoparticle (LNP) Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Lipid Nanoparticle (LNP) Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Lipid Nanoparticle (LNP) Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 PreciGenome
  2. 6.1.1 PreciGenome Company Information
  3. 6.1.2 PreciGenome Business Overview
  4. 6.1.3 PreciGenome Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 PreciGenome Lipid Nanoparticle (LNP) Services Product Portfolio
  6. 6.1.5 PreciGenome Recent Developments
  7. 6.2 Creative Biolabs
  8. 6.2.1 Creative Biolabs Company Information
  9. 6.2.2 Creative Biolabs Business Overview
  10. 6.2.3 Creative Biolabs Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Creative Biolabs Lipid Nanoparticle (LNP) Services Product Portfolio
  12. 6.2.5 Creative Biolabs Recent Developments
  13. 6.3 Genscript
  14. 6.3.1 Genscript Company Information
  15. 6.3.2 Genscript Business Overview
  16. 6.3.3 Genscript Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Genscript Lipid Nanoparticle (LNP) Services Product Portfolio
  18. 6.3.5 Genscript Recent Developments
  19. 6.4 ReciBioPharm
  20. 6.4.1 ReciBioPharm Company Information
  21. 6.4.2 ReciBioPharm Business Overview
  22. 6.4.3 ReciBioPharm Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 ReciBioPharm Lipid Nanoparticle (LNP) Services Product Portfolio
  24. 6.4.5 ReciBioPharm Recent Developments
  25. 6.5 CD Bioparticles
  26. 6.5.1 CD Bioparticles Company Information
  27. 6.5.2 CD Bioparticles Business Overview
  28. 6.5.3 CD Bioparticles Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 CD Bioparticles Lipid Nanoparticle (LNP) Services Product Portfolio
  30. 6.5.5 CD Bioparticles Recent Developments
  31. 6.6 Vernal Biosciences
  32. 6.6.1 Vernal Biosciences Company Information
  33. 6.6.2 Vernal Biosciences Business Overview
  34. 6.6.3 Vernal Biosciences Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Vernal Biosciences Lipid Nanoparticle (LNP) Services Product Portfolio
  36. 6.6.5 Vernal Biosciences Recent Developments
  37. 6.7 Hzymes Biotech
  38. 6.7.1 Hzymes Biotech Company Information
  39. 6.7.2 Hzymes Biotech Business Overview
  40. 6.7.3 Hzymes Biotech Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Hzymes Biotech Lipid Nanoparticle (LNP) Services Product Portfolio
  42. 6.7.5 Hzymes Biotech Recent Developments
  43. 6.8 LipExoGen
  44. 6.8.1 LipExoGen Company Information
  45. 6.8.2 LipExoGen Business Overview
  46. 6.8.3 LipExoGen Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 LipExoGen Lipid Nanoparticle (LNP) Services Product Portfolio
  48. 6.8.5 LipExoGen Recent Developments
  49. 6.9 Evonik
  50. 6.9.1 Evonik Company Information
  51. 6.9.2 Evonik Business Overview
  52. 6.9.3 Evonik Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Evonik Lipid Nanoparticle (LNP) Services Product Portfolio
  54. 6.9.5 Evonik Recent Developments
  55. 6.10 Merck
  56. 6.10.1 Merck Company Information
  57. 6.10.2 Merck Business Overview
  58. 6.10.3 Merck Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Merck Lipid Nanoparticle (LNP) Services Product Portfolio
  60. 6.10.5 Merck Recent Developments
  61. 6.11 Cayman
  62. 6.11.1 Cayman Company Information
  63. 6.11.2 Cayman Business Overview
  64. 6.11.3 Cayman Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Cayman Lipid Nanoparticle (LNP) Services Product Portfolio
  66. 6.11.5 Cayman Recent Developments
  67. 6.12 Echelon
  68. 6.12.1 Echelon Company Information
  69. 6.12.2 Echelon Business Overview
  70. 6.12.3 Echelon Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Echelon Lipid Nanoparticle (LNP) Services Product Portfolio
  72. 6.12.5 Echelon Recent Developments
  73. 6.13 WuXi STA
  74. 6.13.1 WuXi STA Company Information
  75. 6.13.2 WuXi STA Business Overview
  76. 6.13.3 WuXi STA Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 WuXi STA Lipid Nanoparticle (LNP) Services Product Portfolio
  78. 6.13.5 WuXi STA Recent Developments
  79. 6.14 BOC Sciences
  80. 6.14.1 BOC Sciences Company Information
  81. 6.14.2 BOC Sciences Business Overview
  82. 6.14.3 BOC Sciences Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 BOC Sciences Lipid Nanoparticle (LNP) Services Product Portfolio
  84. 6.14.5 BOC Sciences Recent Developments
  85. 6.15 Carcell
  86. 6.15.1 Carcell Company Information
  87. 6.15.2 Carcell Business Overview
  88. 6.15.3 Carcell Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Carcell Lipid Nanoparticle (LNP) Services Product Portfolio
  90. 6.15.5 Carcell Recent Developments
  91. 6.16 Cambridge Bioscience
  92. 6.16.1 Cambridge Bioscience Company Information
  93. 6.16.2 Cambridge Bioscience Business Overview
  94. 6.16.3 Cambridge Bioscience Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Cambridge Bioscience Lipid Nanoparticle (LNP) Services Product Portfolio
  96. 6.16.5 Cambridge Bioscience Recent Developments
  97. 6.17 FluidicLab
  98. 6.17.1 FluidicLab Company Information
  99. 6.17.2 FluidicLab Business Overview
  100. 6.17.3 FluidicLab Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 FluidicLab Lipid Nanoparticle (LNP) Services Product Portfolio
  102. 6.17.5 FluidicLab Recent Developments
  103. 6.18 Guangzhou Anernor Biotechnology
  104. 6.18.1 Guangzhou Anernor Biotechnology Company Information
  105. 6.18.2 Guangzhou Anernor Biotechnology Business Overview
  106. 6.18.3 Guangzhou Anernor Biotechnology Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Guangzhou Anernor Biotechnology Lipid Nanoparticle (LNP) Services Product Portfolio
  108. 6.18.5 Guangzhou Anernor Biotechnology Recent Developments
  109. 6.19 Nanjing Yasmin Biotechnology
  110. 6.19.1 Nanjing Yasmin Biotechnology Company Information
  111. 6.19.2 Nanjing Yasmin Biotechnology Business Overview
  112. 6.19.3 Nanjing Yasmin Biotechnology Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Nanjing Yasmin Biotechnology Lipid Nanoparticle (LNP) Services Product Portfolio
  114. 6.19.5 Nanjing Yasmin Biotechnology Recent Developments
  115. 6.20 vectorbuilder
  116. 6.20.1 vectorbuilder Company Information
  117. 6.20.2 vectorbuilder Business Overview
  118. 6.20.3 vectorbuilder Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 vectorbuilder Lipid Nanoparticle (LNP) Services Product Portfolio
  120. 6.20.5 vectorbuilder Recent Developments
  121. 6.21 Helix Biotech
  122. 6.21.1 Helix Biotech Company Information
  123. 6.21.2 Helix Biotech Business Overview
  124. 6.21.3 Helix Biotech Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Helix Biotech Lipid Nanoparticle (LNP) Services Product Portfolio
  126. 6.21.5 Helix Biotech Recent Developments
  127. 6.22 FUJIFILM Holdings
  128. 6.22.1 FUJIFILM Holdings Company Information
  129. 6.22.2 FUJIFILM Holdings Business Overview
  130. 6.22.3 FUJIFILM Holdings Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 FUJIFILM Holdings Lipid Nanoparticle (LNP) Services Product Portfolio
  132. 6.22.5 FUJIFILM Holdings Recent Developments
  133. 6.23 Ascendia Pharmaceuticals
  134. 6.23.1 Ascendia Pharmaceuticals Company Information
  135. 6.23.2 Ascendia Pharmaceuticals Business Overview
  136. 6.23.3 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Services Product Portfolio
  138. 6.23.5 Ascendia Pharmaceuticals Recent Developments
  139. 6.24 Catalent
  140. 6.24.1 Catalent Company Information
  141. 6.24.2 Catalent Business Overview
  142. 6.24.3 Catalent Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Catalent Lipid Nanoparticle (LNP) Services Product Portfolio
  144. 6.24.5 Catalent Recent Developments
  145. 6.25 Polymun Scientific
  146. 6.25.1 Polymun Scientific Company Information
  147. 6.25.2 Polymun Scientific Business Overview
  148. 6.25.3 Polymun Scientific Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Polymun Scientific Lipid Nanoparticle (LNP) Services Product Portfolio
  150. 6.25.5 Polymun Scientific Recent Developments
  151. 6.26 Wacker
  152. 6.26.1 Wacker Company Information
  153. 6.26.2 Wacker Business Overview
  154. 6.26.3 Wacker Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Wacker Lipid Nanoparticle (LNP) Services Product Portfolio
  156. 6.26.5 Wacker Recent Developments
  157. 6.27 Corden Pharma
  158. 6.27.1 Corden Pharma Company Information
  159. 6.27.2 Corden Pharma Business Overview
  160. 6.27.3 Corden Pharma Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  161. 6.27.4 Corden Pharma Lipid Nanoparticle (LNP) Services Product Portfolio
  162. 6.27.5 Corden Pharma Recent Developments
  163. 6.28 Cytiva
  164. 6.28.1 Cytiva Company Information
  165. 6.28.2 Cytiva Business Overview
  166. 6.28.3 Cytiva Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  167. 6.28.4 Cytiva Lipid Nanoparticle (LNP) Services Product Portfolio
  168. 6.28.5 Cytiva Recent Developments
  169. 6.29 Croda International
  170. 6.29.1 Croda International Company Information
  171. 6.29.2 Croda International Business Overview
  172. 6.29.3 Croda International Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  173. 6.29.4 Croda International Lipid Nanoparticle (LNP) Services Product Portfolio
  174. 6.29.5 Croda International Recent Developments
  175. 6.30 Nippon Fine Chemical
  176. 6.30.1 Nippon Fine Chemical Company Information
  177. 6.30.2 Nippon Fine Chemical Business Overview
  178. 6.30.3 Nippon Fine Chemical Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  179. 6.30.4 Nippon Fine Chemical Lipid Nanoparticle (LNP) Services Product Portfolio
  180. 6.30.5 Nippon Fine Chemical Recent Developments
  181. 6.31 Patheon
  182. 6.31.1 Patheon Company Information
  183. 6.31.2 Patheon Business Overview
  184. 6.31.3 Patheon Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  185. 6.31.4 Patheon Lipid Nanoparticle (LNP) Services Product Portfolio
  186. 6.31.5 Patheon Recent Developments
  187. 6.32 Lonza
  188. 6.32.1 Lonza Company Information
  189. 6.32.2 Lonza Business Overview
  190. 6.32.3 Lonza Lipid Nanoparticle (LNP) Services Revenue, Global Share and Gross Margin (2021-2026)
  191. 6.32.4 Lonza Lipid Nanoparticle (LNP) Services Product Portfolio
  192. 6.32.5 Lonza Recent Developments
7 North America
  1. 7.1 North America Lipid Nanoparticle (LNP) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026)
  3. 7.3 North America Lipid Nanoparticle (LNP) Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Lipid Nanoparticle (LNP) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026)
  3. 8.3 Europe Lipid Nanoparticle (LNP) Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Lipid Nanoparticle (LNP) Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Lipid Nanoparticle (LNP) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026)
  3. 10.3 South America Lipid Nanoparticle (LNP) Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Lipid Nanoparticle (LNP) Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst